Summary
Pfizer Inc. (PFE) filed an 8-K on August 3, 2010, to report its financial results for the second quarter of 2010. The core of this filing is a press release, attached as Exhibit 99, which details the company's performance during the period. Investors should note that this 8-K serves as a notification and incorporation by reference of the press release, rather than containing extensive new narrative details within the 8-K itself. The actual financial figures and operational commentary are found within the referenced press release. Investors looking for specific performance metrics, earnings per share, revenue figures, and management's outlook for the second quarter of 2010 will need to consult Exhibit 99.
Key Highlights
- 1Pfizer Inc. announced its second quarter 2010 financial results via a press release filed on August 3, 2010.
- 2The 8-K filing primarily incorporates by reference a press release (Exhibit 99) containing the detailed financial information.
- 3Investors must refer to Exhibit 99 for specific Q2 2010 financial performance data and commentary.
- 4The filing confirms the official release of Q2 2010 earnings information by Pfizer.
- 5This report serves as a formal notification to the SEC and investors about the Q2 2010 financial outcomes.